These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 27603572)

  • 21. Pharmacogenetics of stomach cancer.
    Toffoli G; Cecchin E
    Suppl Tumori; 2003; 2(5):S19-22. PubMed ID: 12914384
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Pharmacogenetics of anticancer drugs].
    de Chaisemartin L; Loriot MA
    Pathol Biol (Paris); 2005 Mar; 53(2):116-24. PubMed ID: 15708657
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacogenetics: a tool for individualizing antineoplastic therapy.
    Innocenti F; Iyer L; Ratain MJ
    Clin Pharmacokinet; 2000 Nov; 39(5):315-25. PubMed ID: 11108431
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Considerations for rare variants in drug metabolism genes and the clinical implications.
    Drögemöller BI; Wright GE; Warnich L
    Expert Opin Drug Metab Toxicol; 2014 Jun; 10(6):873-84. PubMed ID: 24673405
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Thiopurine S-methyltransferase pharmacogenetics: insights, challenges and future directions.
    Wang L; Weinshilboum R
    Oncogene; 2006 Mar; 25(11):1629-38. PubMed ID: 16550163
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacogenetics and breast cancer management: current status and perspectives.
    Ciccolini J; Fanciullino R; Serdjebi C; Milano G
    Expert Opin Drug Metab Toxicol; 2015 May; 11(5):719-29. PubMed ID: 25690018
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [State of the art of pharmacogenetic diagnostics in drug therapy].
    Kirchheiner J; Seeringer A; Brockmöller J
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2006 Oct; 49(10):995-1003. PubMed ID: 17013776
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacogenetics/genomics of membrane transporters in cancer chemotherapy.
    Huang Y
    Cancer Metastasis Rev; 2007 Mar; 26(1):183-201. PubMed ID: 17323126
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of drug transporter pharmacogenomics on pharmacokinetic and pharmacodynamic variability - considerations for drug development.
    Lai Y; Varma M; Feng B; Stephens JC; Kimoto E; El-Kattan A; Ichikawa K; Kikkawa H; Ono C; Suzuki A; Suzuki M; Yamamoto Y; Tremaine L
    Expert Opin Drug Metab Toxicol; 2012 Jun; 8(6):723-43. PubMed ID: 22509796
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacogenetics for individualized cancer chemotherapy.
    Efferth T; Volm M
    Pharmacol Ther; 2005 Aug; 107(2):155-76. PubMed ID: 15890408
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nucleoside analogs: ready to enter the era of precision medicine?
    Ciccolini J; Serdjebi C; Le Thi Thu H; Lacarelle B; Milano G; Fanciullino R
    Expert Opin Drug Metab Toxicol; 2016 Aug; 12(8):865-77. PubMed ID: 27218825
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacogenetics of drug transporters in the enterohepatic circulation.
    Stieger B; Meier PJ
    Pharmacogenomics; 2011 May; 12(5):611-31. PubMed ID: 21619426
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Germline oncopharmacogenetics, a promising field in cancer therapy.
    Pesenti C; Gusella M; Sirchia SM; Miozzo M
    Cell Oncol (Dordr); 2015 Feb; 38(1):65-89. PubMed ID: 25573079
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of drug transporter pharmacogenetics on cholestasis.
    Dietrich CG; Geier A
    Expert Opin Drug Metab Toxicol; 2014 Nov; 10(11):1533-51. PubMed ID: 25260651
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cancer pharmacogenomics: SNPs, chips, and the individual patient.
    McLeod HL; Yu J
    Cancer Invest; 2003; 21(4):630-40. PubMed ID: 14533451
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacogenetics of genes across the doxorubicin pathway.
    Jamieson D; Boddy AV
    Expert Opin Drug Metab Toxicol; 2011 Oct; 7(10):1201-10. PubMed ID: 21919804
    [TBL] [Abstract][Full Text] [Related]  

  • 37. DMET™ (Drug Metabolism Enzymes and Transporters): a pharmacogenomic platform for precision medicine.
    Arbitrio M; Di Martino MT; Scionti F; Agapito G; Guzzi PH; Cannataro M; Tassone P; Tagliaferri P
    Oncotarget; 2016 Aug; 7(33):54028-54050. PubMed ID: 27304055
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Germline genetic variation, cancer outcome, and pharmacogenetics.
    Coate L; Cuffe S; Horgan A; Hung RJ; Christiani D; Liu G
    J Clin Oncol; 2010 Sep; 28(26):4029-37. PubMed ID: 20679599
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Approaches to the discovery of pharmacogenomic markers in oncology: 2000-2010-2020.
    Huang RS; Dolan ME
    Pharmacogenomics; 2010 Apr; 11(4):471-4. PubMed ID: 20350124
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacogenomics and Global Precision Medicine in the Context of Adverse Drug Reactions: Top 10 Opportunities and Challenges for the Next Decade.
    Alessandrini M; Chaudhry M; Dodgen TM; Pepper MS
    OMICS; 2016 Oct; 20(10):593-603. PubMed ID: 27643672
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.